Compare CIGI & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIGI | NOVT |
|---|---|---|
| Founded | 1972 | 1968 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | 1995 | 1999 |
| Metric | CIGI | NOVT |
|---|---|---|
| Price | $106.94 | $117.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $176.25 | $144.00 |
| AVG Volume (30 Days) | 340.5K | ★ 369.9K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $16.74 | $8.71 |
| Revenue Next Year | $8.04 | $6.47 |
| P/E Ratio | ★ $57.57 | $77.04 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $95.66 | $98.27 |
| 52 Week High | $171.20 | $149.95 |
| Indicator | CIGI | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 43.51 |
| Support Level | $98.97 | $111.58 |
| Resistance Level | $149.12 | $125.37 |
| Average True Range (ATR) | 3.92 | 5.49 |
| MACD | 0.73 | 0.02 |
| Stochastic Oscillator | 73.41 | 42.09 |
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.